STD Diagnostic and Therapeutic Dilemmas: Gonococcal and Chlamydial Infections

Objectives:

Participants wiere able to:

Name three clinical tests available for screening & diagnosis of Gonorrhea & Chlamydia

Describe five commonly encountered clinical diagnostic dilemmas & solutions

Name two new tests available for community-based screening

State sensitivities, specificities, predictive values (negative & positive) for current tests

State/interpret the accurate meaning of test results

State CDC current recommended therapies for each disease.

Physicians, physician assistants, nurse practitioners, midwives, nurses, and other health care providers caring for people at risk for STD/HIV.

Moderator: Mack Carmack, Director of Broadcast Communications, University of Alabama, Birmingham, AL

Frank Biro, MD, Associate Professor, Pediatrics, University of Cincinnati College of Medicine, STD/HIV Prevention Training Center, Cincinnati, OH

Edward (Ned) W. Hook, III, MD, Professor, Medicine/Epidemiology, The University of Alabama at Birmingham, School of Medicine, Medical Director, Birmingham STD/HIV Prevention Training Center, Birmingham, AL

Jeanne Marrazzo, MD, MPH, Assistant Professor, Department of Medicine, Division of Infectious Diseases, University of Washington, Medical Director, Seattle STD/HIV Prevention Training Center, Seattle, WA

David H. Martin, MD, Professor, Internal Medicine & Microbiology, Louisiana State University Medical School, New Orleans, LA

Pablo Sanchez, MD, Associate Professor, Pediatrics, Division of Perinatal-Neonatal Medicine, Division of Pediatric Infectious Diseases, UT Southwestern Medical Center at Dallas, Dallas STD/HIV Prevention Training Center, Dallas, TX

Cathleen M. Walsh, Dr. PH, Health Services Research & Evaluation, Division of STD Prevention, CDC, Atlanta, GA

George D. Wendel, Jr., MD, Professor, Department of OB/GYN, UT Southwestern Medical Center at Dallas, Dallas STD/HIV Prevention Training Center, Dallas, TX

This conference was made possible through funding from the Centers for Disease Control and Prevention.

The University of Cincinnati College of Medicine designates this activity for a maximum of 1.5hours in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours that he/she actually spent in the educational activity. This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Counsel for Continuing Medical Education through the joint sponsorship of the University of Cincinnati and the National Network of STD/HIV PTC. The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing education for physicians.